Product Profile of Amivantamab Plus Chemotherapy in EGFR Exon 20+ NSCLCByTammy McClellan, PharmDJune 17th 2024Tammy McClellan, PharmD, discusses the use of amivantamab plus chemotherapy in patients with non–small cell lung cancer harboring EGFR exon 20 insertion mutations.